title: Serum inhibin B concentration as a prognostic factor for prediction of sperm retrieval in testis biopsy of patients with azoospermia.
abstract: BACKGROUND
  This study was conducted to determine if serum inhibin B concentration can predict spermatogenesis in azoospermic infertile men.
  
  
  METHODS
  This cross-sectional study included 70 patients with male-factor infertility referred to Alvand and Vali-e-Asr Infertility Centers, Tehran, Iran. All patients had azoospermia. Standard evaluation consisted of history and physical examination with extreme attention to sexual history and testis examination including testis size, consistency, and presence of varicocele. Laboratory evaluation done for all cases consisted of FSH, testosterone, LH, prolactin, and inhibin B. Testis biopsy was performed in all cases with acceptable testis volume and FSH. The mean inhibin B level was compared in groups with positive and negative sperm retrieval.
  
  
  RESULTS
  The mean+/-SEM age of 70 azoospermic patients was 32.1+/-6.2 (range: 20 - 50) years. All couples had primary infertility with a mean+/-SEM duration of infertility of 74.3+/-7.7 months. The mean+/-SEM testicular volume was 10.14+/-0.75 mL. The mean+/-SEM FSH and LH levels were 17.55+/-1.68, and 11.33+/-0.99 mIU/mL, respectively. The mean+/-SEM serum prolactin and testosterone levels were 308.77+/-17.35 and 5.45+/-0.91 ng/dL, respectively. The mean+/-SEM serum inhibin B concentration was 138.23+/-28.58 (range: 15 - 1500) pg/mL. Sperm was not retrieved in 82% of the patients; in 13% of the cases, biopsy revealed spermatogenesis. The mean+/-SEM serum FSH level of positive and negative groups was 9.78+/-2.13 and 22.56+/-2.46 mIU/mL, respectively (P<0.05). The mean serum LH, prolactin, and testosterone levels were not statistically different between the two groups. The mean+/-SEM serum inhibin B was 129+/-45.46, and 158.93+/-47.24 pg/mL in positive and negative groups, respectively (P>0.05).
  
  
  CONCLUSIONS
  Inhibin B concentration is not an appropriate predicting factor for testicular spermatogenesis.
authors.affiliation: Department of Urology, Imam Khomeini General Hospital, Medical Sciences/Tehran University, Tehran, Iran.
authors.forename: Mohammad-Reza
authors.initials: MR
authors.lastname: Nowroozi
authors.forename: Keivan
authors.initials: K
authors.lastname: Radkhah
authors.forename: Mohsen
authors.initials: M
authors.lastname: Ayati
authors.forename: Hassan
authors.initials: H
authors.lastname: Jamshidian
authors.forename: Alireza
authors.initials: A
authors.lastname: Ranjbaran
authors.forename: Parviz
authors.initials: P
authors.lastname: Jabalameli
mesh_terms: D000328:Adult; D053713:Azoospermia / Q000097:blood / Q000473:pathology; D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D003430:Cross-Sectional Studies; D006801:Humans; D007265:Inhibins / Q000097:blood*; D016015:Logistic Models; D008297:Male; D011237:Predictive Value of Tests; D011379:Prognosis; D013737:Testis / Q000473:pathology*
chemical_list: D015415:Biomarkers; D007265:Inhibins